Point72 Europe’s Medpace MEDP Stock Holding History

Point72 Europe’s Portfolio MEDP Stock Details MEDP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-11,100	Closed	-$4.49M	–	152
2024 Q1	$4.49M	Buy	11,100 +11,035	+16,977%	+$3.88M	0.4%	82
2023 Q4	$19.9K	Buy	+65	New	+$17.5K	﹤0.01%	347

Other funds holding MEDP

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Riverbridge Partners Minneapolis, Minnesota $3.58B AUM 4.02% 1-Year Est. Return

TD Asset Management Toronto, Ontario, Canada $123B AUM 34.51% 1-Year Est. Return

Bessemer Group Woodbridge, New Jersey $63.6B AUM 28.76% 1-Year Est. Return

Point72 Europe's MEDP Position: Q2 2024 in Review

Point72 Europe sold out of Medpace (MEDP) in Q2 2024, closing a stake of 11,100 shares — an estimated $4.49M sold.

Point72 Europe first reported a position in MEDP in Q4 2023 and held it in 2 quarters. The position peaked at $4.49M in Q1 2024. 623 funds tracked by Wall St. Rank hold MEDP as of Q2 2024.

Point72 Europe reported no remaining Medpace position as of Q2 2024 after selling out during the quarter.
Point72 Europe sold 11,100 Medpace shares in Q2 2024, an estimated $4.49M.
Point72 Europe first reported a position in Medpace in Q4 2023 and held it in 2 quarters.
Point72 Europe's Medpace position peaked at $4.49M in Q1 2024.
623 funds tracked by Wall St. Rank held Medpace as of Q2 2024.

Based on Point72 Europe's 13F filing for Q2 2024, filed 14 Aug 2024.